Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability.
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether naltrexone (an opiate blocking agent
approved for the treatment of alcohol dependence) is more effective in the reduction of
alcohol craving and drinking compared to placebo in individuals with particular genetic
predisposition.